Published in Brain Cogn on August 06, 2009
Pathophysiological distortions in time perception and timed performance. Brain (2011) 1.80
Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front Psychiatry (2014) 0.99
Timing as a window on cognition in schizophrenia. Neuropharmacology (2011) 0.98
Dissociable neural systems for timing: evidence from subjects with basal ganglia lesions. PLoS One (2010) 0.94
On disturbed time continuity in schizophrenia: an elementary impairment in visual perception? Front Psychol (2013) 0.90
Motor deficits in schizophrenia quantified by nonlinear analysis of postural sway. PLoS One (2012) 0.89
Ketamine perturbs perception of the flow of time in healthy volunteers. Psychopharmacology (Berl) (2011) 0.87
The therapeutic potential of the cerebellum in schizophrenia. Front Syst Neurosci (2014) 0.84
Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology (2016) 0.83
Serotonergic hallucinogens as translational models relevant to schizophrenia. Int J Neuropsychopharmacol (2013) 0.82
Impaired Representation of Time in Schizophrenia Is Linked to Positive Symptoms and Cognitive Demand. PLoS One (2013) 0.82
Space and time bisection in schizophrenia. Front Psychol (2013) 0.81
Disrupted modular architecture of cerebellum in schizophrenia: a graph theoretic analysis. Schizophr Bull (2014) 0.81
Explicit Time Deficit in Schizophrenia: Systematic Review and Meta-Analysis Indicate It Is Primary and Not Domain Specific. Schizophr Bull (2015) 0.81
Impaired cerebellar-dependent eyeblink conditioning in first-degree relatives of individuals with schizophrenia. Schizophr Bull (2013) 0.80
Increased timing variability in schizophrenia and bipolar disorder. PLoS One (2014) 0.79
Paced finger-tapping abnormalities in bipolar disorder indicate timing dysfunction. Bipolar Disord (2011) 0.78
More than just tapping: index finger-tapping measures procedural learning in schizophrenia. Schizophr Res (2012) 0.77
Sex differences in interval timing and attention to time in C57Bl/6J mice. Behav Brain Res (2017) 0.75
New Insights into the Nature of Cerebellar-Dependent Eyeblink Conditioning Deficits in Schizophrenia: A Hierarchical Linear Modeling Approach. Front Psychiatry (2016) 0.75
Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation. Biol Psychiatry (2016) 0.75
A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades. Psychopharmacology (Berl) (2015) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull (1998) 3.67
Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry (2000) 3.32
The cerebellum communicates with the basal ganglia. Nat Neurosci (2005) 3.27
A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Arch Gen Psychiatry (1999) 2.93
The evolution of brain activation during temporal processing. Nat Neurosci (2001) 2.92
The disconnection hypothesis. Schizophr Res (1998) 2.89
Neuropharmacology of timing and time perception. Brain Res Cogn Brain Res (1996) 2.89
Selective adjustment of the speed of internal clock and memory processes. J Exp Psychol Anim Behav Process (1983) 2.54
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia. Behav Brain Sci (2003) 2.51
Timing functions of the cerebellum. J Cogn Neurosci (1989) 2.44
Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Res (1994) 2.08
Distributed neural systems underlying the timing of movements. J Neurosci (1997) 2.04
Neuropsychological mechanisms of interval timing behavior. Bioessays (2000) 1.95
Temporal processing in the basal ganglia. Neuropsychology (1998) 1.86
Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res (1988) 1.82
Pyramidical model of schizophrenia. Schizophr Bull (1990) 1.74
Methamphetamine and time estimation. J Exp Psychol Anim Behav Process (1981) 1.65
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction. J Cogn Neurosci (1998) 1.64
The cerebellum predicts the timing of perceptual events. J Neurosci (2008) 1.64
Chaos and schizophrenia: does the method fit the madness? Biol Psychiatry (2003) 1.57
Role of the cerebellum in externally paced rhythmic finger movements. J Neurophysiol (2007) 1.42
Time estimation and reproduction is abnormal in Parkinson's disease. Brain (1992) 1.40
Repetitive TMS of cerebellum interferes with millisecond time processing. Exp Brain Res (2006) 1.32
Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? J Clin Psychopharmacol (2003) 1.25
Affinity for the dopamine D2 receptor predicts neuroleptic potency in decreasing the speed of an internal clock. Pharmacol Biochem Behav (1986) 1.25
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? Int Clin Psychopharmacol (2008) 1.20
Temporal processing dysfunction in schizophrenia. Brain Cogn (2008) 1.19
Voluntary timing and brain function: an information processing approach. Brain Cogn (2002) 1.19
Duration judgements in patients with schizophrenia. Psychol Med (2003) 1.16
Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophrenia. Brain Cogn (2005) 1.14
Schizophrenia and the mechanisms of conscious integration. Brain Res Brain Res Rev (2000) 1.14
The subjective experience of perceptual and cognitive disturbances in schizophrenia. A review of autobiographical accounts. Arch Gen Psychiatry (1974) 1.10
The role of the cerebellum in subsecond time perception: evidence from repetitive transcranial magnetic stimulation. J Cogn Neurosci (2007) 1.08
Brain activation induced by estimation of duration: a PET study. Neuroimage (1996) 1.08
Time estimation in schizophrenia: an fMRI study at adjusted levels of difficulty. Neuroreport (2001) 1.07
Cerebellar functional abnormalities in schizophrenia are suggested by classical eyeblink conditioning. Biol Psychiatry (2000) 1.07
Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans? Neuropsychobiology (1997) 0.95
Impaired conditional discrimination learning in schizophrenia. Schizophr Res (2001) 0.93
Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments. Psychiatry Res (1994) 0.93
Cortical coordination dynamics and the disorganization syndrome in schizophrenia. Neuropsychopharmacology (2003) 0.91
Cerebellar involvement in the explicit representation of temporal information. Ann N Y Acad Sci (1993) 0.91
Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis. Expert Rev Neurother (2009) 0.90
Subjective time estimation in Parkinson's disease. J Neural Transm Suppl (1995) 0.88
Estimation of time and the subclassification of schizophrenic disorders. Percept Mot Skills (1983) 0.87
Estimation of time by patients with positive and negative schizophrenia. Percept Mot Skills (1990) 0.87
Time estimation by healthy subjects and schizophrenic patients: a methodological study. Percept Mot Skills (1983) 0.86
Time perception and schizophrenia. Percept Mot Skills (1977) 0.86
Time estimation among schizophrenics. Percept Mot Skills (1980) 0.86
Schizophrenia as a brain disease. The dopamine receptor story. Arch Neurol (1993) 0.85
The time sense; estimation of one second durations by schizophrenic patients. AMA Arch Neurol Psychiatry (1956) 0.85
Information-processing characteristics of explicit time estimation by patients with schizophrenia and normal controls. Percept Mot Skills (1998) 0.84
Is there a common dopaminergic basis of time perception and reaction time? Neuropsychobiology (1989) 0.84
Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats. Pharmacol Biochem Behav (1996) 0.84
Temporal orientation and time estimation in chronic schizophrenics. J Clin Psychol (1971) 0.83
Cerebellar control of cortico-striatal LTD. Restor Neurol Neurosci (2008) 0.83
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage. Eur J Neurosci (2008) 0.81
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nat Med (2011) 2.11
Modulation of anxiety circuits by serotonergic systems. Stress (2005) 1.81
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci (2004) 1.67
A key role for orexin in panic anxiety. Nat Med (2009) 1.63
Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res (2002) 1.63
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry (2010) 1.62
P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res (2008) 1.52
Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci (2008) 1.48
Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull (2007) 1.36
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci (2008) 1.35
EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am J Psychiatry (2003) 1.35
Steady state responses: electrophysiological assessment of sensory function in schizophrenia. Schizophr Bull (2009) 1.33
Haloperidol impairs learning and error-related negativity in humans. J Cogn Neurosci (2004) 1.29
Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety (2010) 1.29
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety (2010) 1.24
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci (2003) 1.22
Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia. Schizophr Res (2009) 1.22
Event-related potential correlates of task switching and switch costs. Psychophysiology (2005) 1.19
Temporal processing dysfunction in schizophrenia. Brain Cogn (2008) 1.19
Steady state visual evoked potential abnormalities in schizophrenia. Clin Neurophysiol (2005) 1.17
Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J Biol Chem (2011) 1.15
Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport (2004) 1.12
Synchronization dynamics and evidence for a repertoire of network states in resting EEG. Front Comput Neurosci (2012) 1.12
Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides (2004) 1.11
Personality traits in schizophrenia and related personality disorders. Psychiatry Res (2005) 1.11
Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res (2005) 1.11
Orexin, stress, and anxiety/panic states. Prog Brain Res (2012) 1.11
Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol (2012) 1.11
Eye gaze and individual differences consistent with learned attention in associative blocking and highlighting. J Exp Psychol Learn Mem Cogn (2005) 1.09
Timing dysfunctions in schizophrenia span from millisecond to several-second durations. Brain Cogn (2009) 1.07
Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res Bull (2007) 1.06
Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J Psychopharmacol (2010) 1.06
Psychometrically matched visual-processing tasks in schizophrenia spectrum disorders. J Abnorm Psychol (2003) 1.05
The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav (2002) 1.05
Temporal discounting of rewards in patients with bipolar disorder and schizophrenia. J Abnorm Psychol (2011) 1.04
Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information? Schizophr Res (2009) 1.04
Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders. Schizophr Bull (2010) 1.04
The effect of selective attention on the gamma-band auditory steady-state response. Neurosci Lett (2007) 1.03
Neural pathways underlying lactate-induced panic. Neuropsychopharmacology (2007) 1.02
Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol (2005) 1.02
Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography. Biol Psychiatry (2009) 1.02
Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res (2011) 1.02
Personality differences in schizophrenia are related to performance on neuropsychological tasks. J Nerv Ment Dis (2005) 1.02
A multimethod investigation of the behavioral activation system in bipolar disorder. J Abnorm Psychol (2008) 1.02
Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology (2007) 1.01
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today (2008) 1.00
The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress (2006) 0.99
Induction of Fos-immunoreactivity in the rat brain following disinhibition of the dorsomedial hypothalamus. Brain Res (2008) 0.99
Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology (2008) 0.99
Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin. J Psychopharmacol (2004) 0.98
The startle reflex in schizophrenia: habituation and personality correlates. Schizophr Res (2003) 0.97
A new statistical method for testing hypotheses of neuropsychological/MRI relationships in schizophrenia: partial least squares analysis. Schizophr Res (2002) 0.97
Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors. J Neurosci (2006) 0.96
Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res Bull (2006) 0.95
Event related brain potential evidence for preserved attentional set switching in schizophrenia. Schizophr Res (2007) 0.95
Attention and emotional responses to sexual stimuli and their relationship to sexual desire. Arch Sex Behav (2007) 0.95
Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disord (2009) 0.95
Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav (2012) 0.95
Switch and maintenance of task set in schizophrenia. Schizophr Res (2006) 0.95
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int J Neuropsychopharmacol (2009) 0.95
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry (2006) 0.95
A longitudinal twin study of effects of adolescent alcohol abuse on the neurophysiology of attention and orienting. Alcohol Clin Exp Res (2011) 0.94
Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Res (2008) 0.94
Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient. Invest Ophthalmol Vis Sci (2012) 0.94
Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disord (2010) 0.93
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology (2012) 0.93
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J Clin Psychiatry (2008) 0.93